Indication
Hymovis ONE®, Hymovis®, Triluron® and Hyalgan® are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and to
simple analgesics (e.g. acetaminophen).
Important Safety Information
Hymovis ONE®, Hymovis®, Triluron® and Hyalgan® are contraindicated in patients with known hypersensitivity to hyaluronate preparations or patients with infections/skin diseases in the area of the injection site/joint or gram
positive bacterial proteins (Hymovis® only). The safety and effectiveness of Hymovis®, Triluron® and Hyalgan® have not been tested in pregnant women, nursing mothers or children, use in other joints or use with other
intraarticular injectibles. See package insert for full prescribing information including adverse events, warnings, precautions, and side effects. Rx Only
